A novel senolytic drug, seno-7284 ameliorates aging phenotype and age-related cardiometabolic diseases
28 August 2020 (08:00 - 18:00)
Organised by:
Abstract
Slides
About the speaker

Juntendo University School of Medicine, Tokyo (Japan)
51 More presentations in this session
Doctor J. Jehle (Bonn, DE)
Doctor E. Straessler (Berlin, DE)
Blocking of interleukin-1 suppresses both angiotensin II-induced renal inflammation and hypertension
Doctor T. Niida (Tokyo, JP)
Access the full session
The Event
ESC Congress 2020
28 August 2020
08:00 CET
